Basit öğe kaydını göster

dc.contributor.authorAYKAN, F
dc.contributor.authorRIDVANOGULLARI, M
dc.contributor.authorAYDINER, A
dc.contributor.authorANIL, D
dc.contributor.authorSAYIN, U
dc.contributor.authorDINCOL, K
dc.contributor.authorTOPUZ, E
dc.date.accessioned2021-03-05T19:30:01Z
dc.date.available2021-03-05T19:30:01Z
dc.date.issued1993
dc.identifier.citationRIDVANOGULLARI M., AYDINER A., ANIL D., SAYIN U., DINCOL K., TOPUZ E., AYKAN F., "POTENTIATION OF ETOPOSIDE-INDUCED DNA-DAMAGE BY VERAPAMIL IN L-STRAIN CELLS IN-VITRO", JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, cilt.12, ss.255-260, 1993
dc.identifier.issn0392-9078
dc.identifier.othervv_1032021
dc.identifier.otherav_cf908fbd-cf58-433b-ac7c-a6408ee28e23
dc.identifier.urihttp://hdl.handle.net/20.500.12627/137246
dc.description.abstractVerapamil has previously been shown to have enhanced the cytotoxicity of VP-16-213 against malign cell lines in vitro. In this study the cytotoxic effects of verapamil on the cytotoxicity of etoposide against transformed mouse fibroblasts (L-strain cell) were examined. When verapamil was used alone, after 8 hrs, DNA synthesis was increased with respect to the control cells (p<0.01) and the initial increase of DNA synthesis was higher with the lowest concentration of verapamil (2 mu g/ml) (p<0.01). In cells that were treated with verapamil and etoposide, after 16 hrs, etoposide cytotoxicity was enhanced and the DNA synthesis decreased (p<0.01). This enhancement augmented with the increasing doses of verapamil (p<0.01). Although the initial stimulatory effect of verapamil on the DNA synthesis may have some role in the enhancement of etoposide cytotoxicity, the involvement of some other mechanisms is postulated.
dc.language.isoeng
dc.subjectOnkoloji
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectONKOLOJİ
dc.subjectKlinik Tıp
dc.titlePOTENTIATION OF ETOPOSIDE-INDUCED DNA-DAMAGE BY VERAPAMIL IN L-STRAIN CELLS IN-VITRO
dc.typeMakale
dc.relation.journalJOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
dc.contributor.department, ,
dc.identifier.volume12
dc.identifier.issue4
dc.identifier.startpage255
dc.identifier.endpage260
dc.contributor.firstauthorID114646


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster